- Advertisement -spot_img

TAG

Proteovant Therapeutics

SK Biopharmaceuticals acquires majority share of U.S biotech firm

SK Biopharmaceuticals has acquired 60 percent of U.S. biotech company Proteovant Therapeutics for $47.5 million, the company said on Friday. Founded in 2020, Proteovant Therapeutics...

Latest news

- Advertisement -spot_img